Literature DB >> 5961829

Further data on the incidence and genetics of the serum cholinesterase phenotype C5+.

E B Robson, H Harris.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1966        PMID： 5961829     DOI： 10.1111/j.1469-1809.1966.tb00538.x

Source DB:  PubMed          Journal:  Ann Hum Genet        ISSN： 0003-4800            Impact factor:   1.670


× No keyword cloud information.
  12 in total

1.  The relation of sex, age, smoking status, birth rank and parental ages to pseudocholinesterase activity and phenotypes in a sample of Australian Caucasian adults.

Authors:  D N Propert; C J Brackenridge
Journal:  Hum Genet       Date:  1976-05-19       Impact factor: 4.132

Review 2.  Molecular basis of hereditary disease.

Authors:  H Harris
Journal:  Br Med J       Date:  1968-04-20

3.  Gene frequencies at loci determining blood-group and serum-protein polymorphisms in two villages of northwestern Greece.

Authors:  G R Fraser; A G Steinberg; B Defaranas; O Mayo; G Stamatoyannopoulos; A G Motulsky
Journal:  Am J Hum Genet       Date:  1969-01       Impact factor: 11.025

4.  An improved method for the electrophoresis of enzymes using a polyacrylamide-starch gel.

Authors:  B H Parkin; C W Parr
Journal:  Biochem J       Date:  1971-05       Impact factor: 3.857

5.  Cholinesterase isoenzymes in rabbit ocular tissue homogenates.

Authors:  M Furman; M Lazar; I H Leopold
Journal:  Doc Ophthalmol       Date:  1969       Impact factor: 2.379

6.  Population genetic studies on pseudocholinesterase polymorphism in Germany, Czechoslovakia, Finland and among Laps.

Authors:  K Altland; R Bucher; T W Kim; H Busch; C Brockelmann; H W Goedde
Journal:  Humangenetik       Date:  1969-10

7.  Pseudocholinesterase polymorphism among Lapp populations in Finland.

Authors:  S Singh; M Jensen; H W Goedde; W Lehmann; K Pyörälä; A W Eriksson
Journal:  Humangenetik       Date:  1971

Review 8.  On the geographical distribution of pseudocholinesterase variants.

Authors:  H Steegmüller
Journal:  Humangenetik       Date:  1975

9.  Proposed nomenclature for human butyrylcholinesterase genetic variants identified by DNA sequencing.

Authors:  B N La Du; C F Bartels; C P Nogueira; M Arpagaus; O Lockridge
Journal:  Cell Mol Neurobiol       Date:  1991-02       Impact factor: 5.046

Review 10.  Adverse effects of depolarising neuromuscular blocking agents. Incidence, prevention and management.

Authors:  W J Book; M Abel; J B Eisenkraft
Journal:  Drug Saf       Date:  1994-05       Impact factor: 5.606
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.